1975
DOI: 10.1111/j.1749-6632.1975.tb29235.x
|View full text |Cite
|
Sign up to set email alerts
|

THE UTILIZATION OF NUCLEOTIDES BY ANIMAL CELLS*

Abstract: We have extended our studies on the toxicity of several arabinosyl nucleotides to L cells. In contrast to a short-term toxic effect of 9-beta-D-arabinofuranosyladenine (araA), both 9-beta-D-arabinofuranosyladenine 5'-phosphate (araAMP) and 9-beta-D-arabinofuranosyladenine 3',5'-cyclic phosphate produced sustained killing of the fibroblasts. 9-beta-D-Arabinofuranosyladenine 2',5'-cyclic phosphate and 9-beta-D-arabinofuranosyladenine-N1-oxide-5'-phosphate were not toxic, whereas 9-beta-D-arabinofuranosylhypoxant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
7
0

Year Published

1977
1977
2003
2003

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(9 citation statements)
references
References 23 publications
2
7
0
Order By: Relevance
“…When ara-AMP is given to humans, less ara-Hx may be formed. This may account for the finding by Cohen and Plunkett that cytotoxicity of ara-AMP is not reversible, whereas that of ara-A and ara-Hx is reversible (10). The apparent equivalence of ara-A and ara-AMP in the present studies may be due to the abundance of intracellular dephosphorylases in HFF tissue cultures.…”
Section: Matepials and Methodssupporting
confidence: 30%
“…When ara-AMP is given to humans, less ara-Hx may be formed. This may account for the finding by Cohen and Plunkett that cytotoxicity of ara-AMP is not reversible, whereas that of ara-A and ara-Hx is reversible (10). The apparent equivalence of ara-A and ara-AMP in the present studies may be due to the abundance of intracellular dephosphorylases in HFF tissue cultures.…”
Section: Matepials and Methodssupporting
confidence: 30%
“…These phosphorylated derivatives are not active therapeutically in their own right because they do not cross lipid cell membranes efficiently (Leibman and Heidelberg, 1955;Roll et aI., 1956, Lichtenstein et al, 1960Cohen and Plunkett, 1975). Moreover, they are readily dephosphorylated on cell surfaces and in extracellular fluids by nonspecific phosphohydrolases (Schrecker, 1968;Ho, 1971).…”
Section: Introductionmentioning
confidence: 94%
“…In general the therapeutic properties of preformed nucleotides are no better than those of their nucleoside precursors; this being attributed to poor membrane penetration by the charged phosphates (Cohen and Plunkett, 1975). Many attempts have been made to prepare uncharged, masked phosphates as membrane-soluble delivery forms of the free bio-active nucleotides.…”
Section: Introductionmentioning
confidence: 99%